Is Mavyret better than Harvoni?

Drugs.com

Official answer

by Drugs.com

Mavyret and Harvoni are both direct-acting antiviral therapies for the treatment of hepatitis C virus (HCV) infection. Mavyret contains glecaprevir and pibrentasvir and is available in the form of tablets or oral pellets. Harvoni also comes in the form of tablets and oral pellets and contains ledipasvir and sofosbuvir.

Mavyret is reported to have some advantages over Harvoni including the number of HCV genotypes it covers, the length of treatment required, and the cost of a course of treatment.

Mavyret is approved to treat chronic HCV genotypes 1, 2, 3, 4, 5 or 6 infection in patients without cirrhosis or with compensated cirrhosis (Child-Pugh A), whereas Harvoni is only approved to treat genotypes 1, 4, 5, or 6.

In addition, Mavyret is typically given for only 8 weeks, whereas Harvoni is given for 12 weeks.

Another advantage of Mavyret is the price. When Mavyret was first approved in 2017, AbbVie, which makes the drug, opted for a pricing strategy that made it cheaper than other options and which quickly allowed it to grow its market share.

The cost of Mavyret without discounts is reported to cost from $27,580.60 for an 8 week supply, whereas a 12 week supply of Harvoni costs from $US98,686.50 without discounts. An authorised generic version of Harvoni is also available and costs from $US30,268.50.

Related medical questions

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords